Longitudinal kidney function outcome in aging testicular cancer survivors
Nome, Ragnhild Veline; Småstuen, Milada Cvancarova; Bjøro, Trine; Kiserud, Cecilie E.; Fosså, Sophie Dorothea
Journal article, Peer reviewed
Published version
Permanent lenke
https://hdl.handle.net/10642/9489Utgivelsesdato
2020-02-11Metadata
Vis full innførselSamlinger
Originalversjon
Nome, Småstuen, Bjøro, Kiserud, Fosså. Longitudinal kidney function outcome in aging testicular cancer survivors. Acta Oncologica. 2020;59(4):467-474Sammendrag
Purpose: Testicular cancer survivors (TCSs) have increased risk of reduced kidney function related to
treatment burden, but longitudinal studies of renal outcome in aging TCSs have been lacking. This
longitudinal study describes age- and treatment-related kidney function changes in TCSs compared to
a comparison group from the general population.
Patients and methods: Estimated glomerular filtration rate (eGFR) was determined in blood samples
from Norwegian TCSs (diagnosed 1980–1994) and surveyed median 11, 19 and 26 years since diagnosis (Survey1 [N ¼ 1273], 2 [N ¼ 849] and 3 [N ¼ 670]) defining four treatment groups; Surgery only,
Radiotherapy (RT) only, Cisplatin-based chemotherapy (CBCT) 850 mg and High CBCT/RT >850 mg
cisplatin or any combination of CBCT with RT. A comparison group was constructed from similarly
aged men who participated in a population-based health survey. By multiple linear regressions and
generalized mixed models for repeated measurements, we studied difference in eGFR between TCSs
and the comparison group for all TCSs combined and stratified by treatment modality.
Results: At Survey 1, the kidney function for the youngest TCSs combined versus the comparison
group was significantly reduced by mean six units (mL/min/1.73 m2
) with further decline to mean 12
units at Survey 3. The kidney function was significantly reduced in all treatment groups with the largest differences emerging for TCSs from the High CBCT/RT Group, thus indicating a deteriorating
impact of high cumulative doses of cisplatin.
Conclusion: Collated to the comparison group, the kidney function in TCSs became increasingly
impaired during nearly three post-treatment decades, related to the treatment modality. Early detection and intervention of kidney dysfunction is important to reduce the risk of TCSs’ long-term morbidity and mortality related to nephrotoxicity, such as cardio-vascular diseases.
Utgiver
Taylor & FrancisSerie
Acta Oncologica;Volume 59, 2020 - Issue 4Tidsskrift
Acta Oncologica
Med mindre annet er angitt, så er denne innførselen lisensiert som Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) License
Beslektede innførsler
Viser innførsler beslektet ved tittel, forfatter og emneord.
-
Bone turnover markers are associated with bone density, but not with fracture in end stage kidney disease: a cross-sectional study
Jørgensen, Hanne Skou; Winther, Simon; Bøttcher, Morten; Hauge, Ellen Margrethe; Rejnmark, Lars; Svensson, My Hanna Sofie; Ivarsen, Per (BMC Nephrology;18(1), Journal article; Peer reviewed, 2017-09-06)Background Fracture risk is increased in chronic kidney disease (CKD), but assessment of bone fragility remains controversial in these patients. This study investigated the associations between bone turnover markers, bone ... -
Characterization of Differentially Expressed miRNAs and Their Predicted Target Transcripts during Smoltification and Adaptation to Seawater in Head Kidney of Atlantic Salmon
Shwe, Alice; Østbye, Tone-Kari K; Krasnov, Aleksei; Ramberg, Sigmund; Andreassen, Rune (Genes;Volume 11, Issue 9, Journal article; Peer reviewed, 2020-09-08)Smoltification and early seawater phase are critical developmental periods with physiological and biochemical changes in Atlantic salmon that facilitates survival in saltwater. MicroRNAs (miRNAs) are known to have important ... -
Bioavailable Testosterone Is Positively Associated With Bone Mineral Density in Male Kidney Transplantation Candidates
Jørgensen, Hanne Skou; Winther, Simon; Bøttcher, Morten; Hauge, Ellen-Margrethe; Rejnmark, Lars; Svensson, My Hanna Sofie; Ivarsen, Per (Kidney international reports;3(3), Journal article; Peer reviewed, 2018-05)Introduction Low levels of sex hormones are common in patients with chronic kidney disease (CKD) and may be a contributing factor to bone fragility. We investigated associations between levels of sex hormones and bone ...